- Home
- GOSS vs BAND Comparison
GOSS vs BAND Comparison
Compare GOSS & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- BAND
- Stock Information
- Founded
- GOSS 2015
- BAND 2000
- Country
- GOSS United States
- BAND United States
- Employees
- GOSS N/A
- BAND N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- BAND Computer Software: Prepackaged Software
- Sector
- GOSS Health Care
- BAND Technology
- Exchange
- GOSS Nasdaq
- BAND Nasdaq
- Market Cap
- GOSS 347.8M
- BAND 431.0M
- IPO Year
- GOSS 2019
- BAND 2017
- Fundamental
- Price
- GOSS $2.47
- BAND $15.00
- Analyst Decision
- GOSS Strong Buy
- BAND Buy
- Analyst Count
- GOSS 4
- BAND 6
- Target Price
- GOSS $8.50
- BAND $20.80
- AVG Volume (30 Days)
- GOSS 3.1M
- BAND 190.8K
- Earning Date
- GOSS 08-05-2025
- BAND 10-30-2025
- Dividend Yield
- GOSS N/A
- BAND N/A
- EPS Growth
- GOSS N/A
- BAND N/A
- EPS
- GOSS N/A
- BAND N/A
- Revenue
- GOSS $40,237,000.00
- BAND $758,106,000.00
- Revenue This Year
- GOSS N/A
- BAND $2.48
- Revenue Next Year
- GOSS $30.65
- BAND $13.24
- P/E Ratio
- GOSS N/A
- BAND N/A
- Revenue Growth
- GOSS N/A
- BAND 14.51
- 52 Week Low
- GOSS $0.66
- BAND $11.33
- 52 Week High
- GOSS $2.65
- BAND $23.00
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- BAND 56.17
- Support Level
- GOSS $2.38
- BAND $14.21
- Resistance Level
- GOSS $2.65
- BAND $14.84
- Average True Range (ATR)
- GOSS 0.15
- BAND 0.49
- MACD
- GOSS 0.03
- BAND 0.15
- Stochastic Oscillator
- GOSS 76.67
- BAND 90.04
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.